| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |